
Steven H. Collis is Chairman, President, and Chief Executive Officer of Cencora, Inc. Under Steve’s leadership, the company has experienced tremendous financial growth with annual revenue tripling from $80 billion since being named CEO in 2011, as well as significant global expansion with more than 46,000 team members spread across more than 50 countries.
Under Steve’s direction, several strategic investments and acquisitions enabled the company to expand its breadth of services and solutions, resulting in unprecedented partnerships, increased global reach, and deep expertise that is accelerating innovation and improving access to healthcare in meaningful ways. In 2012, Steve spearheaded Cencora’s (formerly AmerisourceBergen) acquisition of World Courier, a premier global specialty provider of transportation, storage, and distribution services for global clinical trials. The acquisition strengthened the company’s worldwide offerings to global biopharmaceutical partners and expanded specialty services outside of North America for the first time in company history.
The following year, Steve established an innovative partnership with Walgreens Boots Alliance, marking the first time a national pharmacy chain turned over its pharmaceutical distribution to a wholesaler and collaborated for generic pharmaceuticals sourcing. Then in 2015, Steve’s vision to deliver value in diverse aspects of patient care and expand in growing markets led to the acquisition of MWI Veterinary Supply. As a result, the Wall Street Journal named Steve as the best performing chief executive in the Philadelphia region for 2015, and Barron’s ranked the company as No. 1 on their list of the 500 top performing companies in 2016 and 2017.
In 2021, Cencora completed the acquisition of European-based Alliance Healthcare, enhancing the company’s reach within pharmaceutical distribution, increasing the breadth of its global manufacturer services and solutions, and advancing the company’s ability to provide innovative, global healthcare solutions for customers and patients around the world. To deliver on his vision of uniting the company’s business under one brand that better reflects its global reach and its position at the center of the pharmaceutical supply chain, Steve oversaw the transition of the company from AmerisourceBergen Corporation to Cencora, Inc. in 2023.
Additionally, Steve has been an advocate for fulfilling Cencora’s purpose of creating healthier futures and deepening the company’s commitment to diversity, equity, and inclusion. During his tenure the company created its first enterprise-wide, nonprofit charitable organization to support health-related causes that enrich the global community and established the DEI Global Council. Cencora was named a DiversityInc Noteworthy Company five times since 2017. The company was also honored by the Women’s Forum of New York as a leading company for gender balance on its board of directors and as a best place to work for disability inclusion by Disability:IN.
Steve’s career with Cencora spans nearly three decades and includes time leading the company’s specialty and wholesale distribution businesses. He helped found the former Specialty Group business in 1994 and grew it to be the market leader in specialty pharmaceutical distribution and product commercialization services.
In addition to serving as chairman of Cencora’s board of directors, he serves on the board of the International Federation of Pharmaceutical Wholesalers, is a founding Vice Chairman of the American Cancer Society’s CEOs Against Cancer Greater Philadelphia Chapter, and serves on the board of governors for the American Red Cross.
He earned a Bachelor of Commerce degree with honors from the University of Witwatersrand in Johannesburg, South Africa.
CXO UNION(cxounion.cn)转载而成,来源于官网;编辑/翻译:CXO UNIONCXO联盟小C。
如需加入CXO UNION(CXO联盟)高管社群,请联系社群小伙伴哦~

免责声明: 本网站(http://www.cxounion.cn/)内容主要来自原创、合作媒体供稿和第三方投稿,凡在本网站出现的信息,均仅供参考。本网站将尽力确保所提供信息的准确性及可靠性,但不保证有关资料的准确性及可靠性,读者在使用前请进一步核实,并对任何自主决定的行为负责。本网站对有关资料所引致的错误、不确或遗漏,概不负任何法律责任。
本网站刊载的所有内容(包括但不仅限文字、图片、LOGO、音频、视频、软件、程序等) 版权归原作者所有。任何单位或个人认为本网站中的内容可能涉嫌侵犯其知识产权或存在不实内容时,请及时通知本站,予以删除。
如需加入CXO UNION(CXO联盟)高管社群,请联系社群小伙伴哦~

免责声明: 本网站(http://www.cxounion.cn/)内容主要来自原创、合作媒体供稿和第三方投稿,凡在本网站出现的信息,均仅供参考。本网站将尽力确保所提供信息的准确性及可靠性,但不保证有关资料的准确性及可靠性,读者在使用前请进一步核实,并对任何自主决定的行为负责。本网站对有关资料所引致的错误、不确或遗漏,概不负任何法律责任。
本网站刊载的所有内容(包括但不仅限文字、图片、LOGO、音频、视频、软件、程序等) 版权归原作者所有。任何单位或个人认为本网站中的内容可能涉嫌侵犯其知识产权或存在不实内容时,请及时通知本站,予以删除。
Search
Popular Posts
-
2024数字化灯塔案例评选申报开启!
“2024数字化灯塔案例评选”于3月正式启动,诚挚欢迎业界同仁自荐和推荐,一起推动产业数字化进程,助力赋能企业…
-
2024 X-Award星盘奖申报通道已开启!
X-Award星盘奖是数字化转型服务、IT服务行业重要的商业奖项,旨在表彰行业里提供杰出数字化转型服务与IT服…
-
2024 N-Award星云奖申报通道已开启!
N-Award是数字化转型领域重要的商业奖项,旨在表彰那些以非凡的远见、超群的领导才能和卓越的成就来激励他人的…





